201 related articles for article (PubMed ID: 20335613)
1. An in vitro investigation of synergy or antagonism between antimicrobial combinations against isolates from bacterial keratitis.
Sueke H; Kaye SB; Neal T; Hall A; Tuft S; Parry CM
Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4151-5. PubMed ID: 20335613
[TBL] [Abstract][Full Text] [Related]
2. Minimum inhibitory concentrations of standard and novel antimicrobials for isolates from bacterial keratitis.
Sueke H; Kaye S; Neal T; Murphy C; Hall A; Whittaker D; Tuft S; Parry C
Invest Ophthalmol Vis Sci; 2010 May; 51(5):2519-24. PubMed ID: 20019362
[TBL] [Abstract][Full Text] [Related]
3. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of synergistic activity of bovine lactoferricin with antibiotics in corneal infection.
Oo TZ; Cole N; Garthwaite L; Willcox MD; Zhu H
J Antimicrob Chemother; 2010 Jun; 65(6):1243-51. PubMed ID: 20375033
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods.
Moody JA; Gerding DN; Peterson LR
Am J Med; 1987 Apr; 82(4A):44-54. PubMed ID: 3107380
[TBL] [Abstract][Full Text] [Related]
6. In vitro synergy of ciprofloxacin and gatifloxacin against ciprofloxacin-resistant Pseudomonas aeruginosa.
Pankey GA; Ashcraft DS
Antimicrob Agents Chemother; 2005 Jul; 49(7):2959-64. PubMed ID: 15980375
[TBL] [Abstract][Full Text] [Related]
7. Combination effect of antibiotics against bacteria isolated from keratitis using fractional inhibitory concentration index.
Suzuki T; Ohashi Y
Cornea; 2013 Jul; 32(7):e156-60. PubMed ID: 23665643
[TBL] [Abstract][Full Text] [Related]
8. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
Cetinkaya E; Coban AY; Durupinar B
Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
[TBL] [Abstract][Full Text] [Related]
9. In vitro synergism of beta-lactams with ciprofloxacin and moxifloxacin against genetically distinct multidrug-resistant isolates of Pseudomonas aeruginosa.
Kanellakopoulou K; Sarafis P; Galani I; Giamarellou H; Giamarellos-Bourboulis EJ
Int J Antimicrob Agents; 2008 Jul; 32(1):33-9. PubMed ID: 18538547
[TBL] [Abstract][Full Text] [Related]
10. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.
Thamlikitkul V
J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906
[TBL] [Abstract][Full Text] [Related]
11. Determination of the synergy of antibiotic combinations by an overlay inoculum susceptibility disc method.
Chinwuba ZG; Chiori CO; Ghobashy AA; Okore VC
Arzneimittelforschung; 1991 Feb; 41(2):148-50. PubMed ID: 1904228
[TBL] [Abstract][Full Text] [Related]
12. In vitro synergy of ciprofloxacin and three other antibiotics against Bacteroides fragilis.
Esposito S; Gupta A; Thadepalli H
Drugs Exp Clin Res; 1987; 13(8):489-92. PubMed ID: 3428131
[TBL] [Abstract][Full Text] [Related]
13. Potential synergy activity of the novel ceragenin, CSA-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa.
Chin JN; Jones RN; Sader HS; Savage PB; Rybak MJ
J Antimicrob Chemother; 2008 Feb; 61(2):365-70. PubMed ID: 18079128
[TBL] [Abstract][Full Text] [Related]
14. Ticarcillin-tobramycin-rifampin: in vitro synergy of the triplet combination against Pseudomonas aeruginosa.
Zuravleff JJ; Yu VL; Yee RB
J Lab Clin Med; 1983 Jun; 101(6):896-902. PubMed ID: 6406628
[TBL] [Abstract][Full Text] [Related]
15. Etest synergy testing of clinical isolates of Staphylococcus aureus demonstrating heterogeneous resistance to vancomycin.
Tsuji BT; Rybak MJ
Diagn Microbiol Infect Dis; 2006 Jan; 54(1):73-7. PubMed ID: 16368477
[TBL] [Abstract][Full Text] [Related]
16. Combined effects of panipenem and aminoglycosides on methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in vitro.
Katou K; Nakamura A; Kato T; Tonegawa K; Kutsuna T; Niwa T; Morita H; Itoh M
Chemotherapy; 2005 Oct; 51(6):387-91. PubMed ID: 16227698
[TBL] [Abstract][Full Text] [Related]
17. [The combined effect of methicillin and teicoplanin against Staphylococcus aureus strains investigated in vitro].
Młynarczyk A; Młynarczyk G; Luczak M
Med Dosw Mikrobiol; 2005; 57(1):1-6. PubMed ID: 16130290
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of lauric acid or myristylamine in combination with six antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA).
Kitahara T; Aoyama Y; Hirakata Y; Kamihira S; Kohno S; Ichikawa N; Nakashima M; Sasaki H; Higuchi S
Int J Antimicrob Agents; 2006 Jan; 27(1):51-7. PubMed ID: 16318911
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection.
Giacometti A; Cirioni O; Kamysz W; Silvestri C; Licci A; Riva A; Łukasiak J; Scalise G
Peptides; 2005 Nov; 26(11):2111-6. PubMed ID: 16269345
[TBL] [Abstract][Full Text] [Related]
20. Synergy of fosfomycin with beta-lactam antibiotics against staphylococci and aerobic gram-negative bacilli.
Chin NX; Neu NM; Neu HC
Drugs Exp Clin Res; 1986; 12(12):943-7. PubMed ID: 3569007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]